BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$16.30
0.00 (0.00%)
▲
5d:
-11.89%
30d:
-25.84%
90d:
-19.11%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: Mar 24, 2026
0d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $16.30, which is considered oversold relative to its 30-day fair value range of $17.18 to $24.51.
Technical Outlook: Technically, BNR is in a uptrend. Immediate support is located at $15.79, while resistance sits at $22.50.
Market Sentiment: BNR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BNR is in a uptrend. Immediate support is located at $15.79, while resistance sits at $22.50.
Market Sentiment: BNR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$17.18 -
$24.51
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 75.3% above Wall St target ($4.03)
- CAUTION: 5-day price weakness (-11.9%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$17.18 -
$24.51
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$15.79
Resistance Level
$22.50
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Wall Street Target
$4.03
(-75.3%)
Revenue Growth (YoY)
0.2%
Profit Margin
-10.3%
Share & Embed Analysis
Last updated: April 02, 2026 12:38 PM ET
Data refreshes hourly during market hours. Next update: 1:38 PM
Data refreshes hourly during market hours. Next update: 1:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$664 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 66 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$133 | 62 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 66 BUY |
